Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02335307 · ClinicalTrials.gov registry record
Implementing Genomics in Practice (IGNITE) Proof of Concept Study: Genotyping in Family Medicine Clinics
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 505
- Enrollment target
NCT02335307: Completed study, sponsored by University of Florida.
NCT02335307 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 505 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02335307 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 505 participants
- Enrollment target
Study Summary
This study will examine the effect of having genotype information on pain management and pain control for patients treated in family medicine clinics. This study will also examine physician-perceived usefulness of genotype information. Patients will be enrolled from family medicine clinics serving as either implementation sites or control sites. Patients from implementation sites will undergo genotyping, while those from control sites will not by genotyped.
Primary Outcome
Patient Reported Outcomes Measurement Information System (PROMIS) measures will be used to assess pain intensity, physical functioning, and emotional functioning. There are 10 subscales on the PROMIS questionnaire that address the domains of pain, pain functioning, and emotional functioning. At least 4 (and up to 30) items are used to derive a score for each subscale. A computer adaptive version of the questionnaire based on item response theory will be used to administer the survey. A score of
Interventions
- GENETIC CYP2D6 genotyping
- OTHER Pain assessment questionnaire
- OTHER Physician assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 505 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-10-25 |
What the finished NCT02335307 record still lists
NCT02335307 is an observational study that tracks outcomes without assigning an intervention. The registered 505 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which CYP2D6 genotyping is the first listed.
NCT02335307 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02335307 about?
NCT02335307 is a clinical study titled "Implementing Genomics in Practice (IGNITE) Proof of Concept Study: Genotyping in Family Medicine Clinics". This study will examine the effect of having genotype information on pain management and pain control for patients treated in family medicine clinics. This study will also examine physician-perceived usefulness of genotype information. Patients will be enrolled from family medicine clinics serving a...
What is the current status of trial NCT02335307?
This trial is currently completed. The enrollment target is 505 participants. The study started on 2015-06. Estimated completion is 2017-10-25.
What interventions are being tested in trial NCT02335307?
The interventions under investigation include: CYP2D6 genotyping (GENETIC), Pain assessment questionnaire (OTHER), Physician assessment (OTHER).
Who is sponsoring clinical trial NCT02335307?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05069428 · 506 participants · Phase 4
Delirium Reduction With Ramelteon
- NCT05797168 · 506 participants · Phase 1
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- NCT05846282 · 504 participants · NA
Students Rising Above: Offsetting the Health and Mental Health Costs of Resilience
- NCT06072131 · 504 participants · Phase 3
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia